Vidipha Central Pharmaceutical JSC (HOSE:VDP)
Vietnam · Delayed Price · Currency is VND 31,950
+450 (1.43%)
At close: Nov 2, 2026
HOSE:VDP Financials Overview
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 |
Revenue Revenue Growth | 1,010,187 | 985,637 | 934,487 | 1,019,317 | 1,007,796 | 206,952 |
Revenue Growth | 13.75% | 5.47% | -8.32% | 1.14% | 386.97% | 8.10% |
Gross Profit Gross Profit Growth | 277,277 | 257,069 | 229,739 | 270,580 | 252,388 | 43,904 |
Operating Income Operating Income Growth | 85,634 | 82,759 | 81,866 | 99,160 | 90,659 | 25,813 |
Net Income Net Income Growth | 66,143 | 63,807 | 71,823 | 80,219 | 73,548 | 27,507 |
Earnings Per Share EPS Growth | 2995.14 | 2889.38 | 3252.36 | 3971.57 | 3641.32 | 3820.00 |
EPS Growth | - | -11.16% | -18.11% | 9.07% | -4.68% | -1.16% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 |
Cash & Investments Cash & Investments Growth | 448,408 | 433,356 | 316,621 | 332,988 | 297,815 | 73,166 |
Total Debt Total Debt Growth | 189,252 | 198,387 | 258,438 | 273,139 | 336,307 | - |
Net Cash (Debt) Net Cash Growth | 259,156 | 234,969 | 58,183 | 59,848 | -38,491 | 73,166 |
Net Cash Growth | - | 303.84% | -2.78% | - | - | 23.57% |
Net Cash Per Share Net Cash Per Share Growth | 11735.32 | 10640.06 | 2634.69 | 2963.04 | -1905.67 | 10160.92 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 |
Operating Cash Flow Operating Cash Flow Growth | 290,757 | 238,229 | 34,493 | 108,744 | 11,054 | 26,782 |
Capital Expenditures CapEx Growth | -17,579 | -20,962 | -13,381 | -59,836 | -64,955 | -1,970 |
Free Cash Flow Free Cash Flow Growth | 273,178 | 217,267 | 21,112 | 48,907 | -53,901 | 24,811 |
Free Cash Flow Growth | 283.06% | 929.13% | -56.83% | - | - | 17.98% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 |
Gross Margin | 27.45% | 26.08% | 24.58% | 26.55% | 25.04% | 21.21% |
Operating Margin | 8.48% | 8.40% | 8.76% | 9.73% | 9.00% | 12.47% |
Pretax Margin | 8.57% | 8.48% | 9.67% | 9.87% | 9.26% | 14.75% |
Profit Margin | 6.55% | 6.47% | 7.69% | 7.87% | 7.30% | 13.29% |
FCF Margin | 27.04% | 22.04% | 2.26% | 4.80% | -5.35% | 11.99% |
Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 |
Dividend Per Share Dividend Per Share Growth | 2500.000 | - | 2500.000 |
Dividend Per Share Growth | - | - | - |
Dividend Yield | 7.83% | - | 6.76% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 |
PE Ratio | 10.67 | 20.07 | 11.38 | 8.95 | 8.58 | - |
Forward PE | - | 14.65 | 14.65 | 14.65 | 14.65 | - |
P/FCF Ratio | 2.58 | 5.90 | 38.70 | 14.68 | - | - |
PS Ratio | 0.70 | 1.30 | 0.87 | 0.70 | 0.63 | - |